The DOI matches its Crossref record; 72 of the 73 references it cites were found in a registry or an index.
Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia
Open accessAbstract
Genetic and epigenetic intra-tumoral heterogeneity cooperate to shape the evolutionary course of cancer 1. Chronic lymphocytic leukaemia (CLL) is a highly informative model for cancer evolution as it undergoes substantial genetic diversification and evolution after therapy 2,3. The CLL epigenome is also an important disease-defining feature 4,5, and growing populations of cells in CLL diversify by stochastic changes in DNA methylation known as epimutations 6. However, previous studies using bulk sequencing methods to analyse the patterns of DNA methylation were unable to determine whether epimutations affect CLL populations homogeneously. Here, to measure the epimutation rate at single-cell resolution, we applied multiplexed single-cell reduced-representation bisulfite sequencing to B cells from healthy donors and patients with CLL. We observed that the common clonal origin of CLL results in a consistently increased epimutation rate, with low variability in the cell-to-cell epimutation rate. By contrast, variable epimutation rates across healthy B cells reflect diverse evolutionary ages across the trajectory of B cell differentiation, consistent with epimutations serving as a molecular clock. Heritable epimutation information allowed us to reconstruct lineages at high-resolution with single-cell data, and to apply this directly to patient samples. The CLL lineage tree shape revealed earlier branching and longer branch lengths than in normal B cells, reflecting rapid drift after the initial malignant transformation and a greater proliferative history. Integration of single-cell bisulfite sequencing analysis with single-cell transcriptomes and genotyping confirmed that genetic subclones mapped to distinct clades, as inferred solely on the basis of epimutation information. Finally, to examine potential lineage biases during therapy, we profiled serial samples during ibrutinib-associated lymphocytosis, and identified clades of cells that were preferentially expelled from the lymph node after treatment, marked by distinct transcriptional profiles. The single-cell integration of genetic, epigenetic and transcriptional information thus charts the lineage history of CLL and its evolution with therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another study combined single-cell transcriptome and DNA methylome data to construct a chronic lymphocytic leukaemia (CLL) lineage tree based on random DNA methylation changes, finding that certain CLL lineages were preferentially affected by drug treatment143.”
From The technological landscape and applications of single-cell multi-omics (2023) · cites this paper as [143]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
IQ-TREE: A Fast and Effective Stochastic Algorithm for Estimating Maximum-Likelihood Phylogenies
Nguyen, L.-T., Schmidt, H. A., von Haeseler, A., & Minh, B. Q. (2015) · Molecular Biology and Evolution · doi:10.1093/molbev/msu300 · Cited by 26,046
ModelFinder: fast model selection for accurate phylogenetic estimates
Kalyaanamoorthy, S., Minh, B. Q., Wong, T. K. F., von Haeseler, A., & Jermiin, L. S. (2017) · Nature Methods · doi:10.1038/nmeth.4285 · Cited by 18,449
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Self-citationUFBoot2: Improving the Ultrafast Bootstrap Approximation
Hoang, D. T., Chernomor, O., von Haeseler, A., Minh, B. Q., & Vinh, L. S. (2018) · Molecular Biology and Evolution · doi:10.1093/molbev/msx281 · Cited by 10,881
Cited by
Sorted by citations
Items 101–200 of 263
Epigenetic dysregulation in cancer: mechanisms, diagnostic biomarkers and therapeutic strategies
Imran, K., Iqbal, M. J., Ahmed, M. M., Khalid, A., Cortés, H., Reyes‐Hernández, O. D., Figueroa‐González, G., Leyva‐Gómez, G., Falzone, L., Libra, M., et al. (2025) · Medical Oncology · doi:10.1007/s12032-025-02905-z · Cited by 26
Single-Cell Epigenomics Reveals Mechanisms of Cancer Progression
LaFave, L. M., Savage, R. E., & Buenrostro, J. D. (2022) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-070620-094453 · Cited by 20
Single-cell sequencing in hematology
Brierley, C. K., & Mead, A. J. (2019) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000613 · Cited by 19
Clonal Evolution of High-Risk Chronic Lymphocytic Leukemia: A Contemporary Perspective
Kwok, M., & Wu, C. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.790004 · Cited by 20
Self-citationThe role of single-cell genomics in human genetics
Sreenivasan, V. K. A., Balachandran, S., & Spielmann, M. (2022) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2022-108588 · Cited by 19
Single-Cell DNA Methylation Analysis in Cancer
O’Neill, H., Lee, H. J., Gupta, I., Rodger, E. J., & Chatterjee, A. (2022) · Cancers · doi:10.3390/cancers14246171 · Cited by 19
Celebrating 20 Years of IGHV Mutation Analysis in CLL
Chiorazzi, N., & Stevenson, F. K. (2020) · HemaSphere · doi:10.1097/hs9.0000000000000334 · Cited by 20
Odell, S. C., Taki, F., Klein, S. L., Chen, R. J., Levine, O. B., Skelly, M. J., Nabila, A., Brindley, E., Toth, J. G., Dündar, F., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107789 · Cited by 17
Self-citationNucleosome repositioning in chronic lymphocytic leukemiaPreprint
Piroeva, K. V., McDonald, C., Xanthopoulos, C., Fox, C., Clarkson, C. T., Mallm, J., Vainshtein, Y., Ruje, L., Klett, L. C., Stilgenbauer, S., et al. (2023) · Genome Research · doi:10.1101/gr.277298.122 · Cited by 18
Cheng, T., Zhou, C., Bian, S., Sobeck, K., & Liu, Y. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03288-3 · Cited by 19
Lineage tracing in human tissues
Gabbutt, C., Wright, N. A., Baker, A., Shibata, D. K., & Graham, T. A. (2022) · The Journal of Pathology · doi:10.1002/path.5911 · Cited by 16
The transcriptional legacy of developmental stochasticity
Ballouz, S., Kawaguchi, R. K., Peña, M. T., Fischer, S., Crow, M., French, L., Knight, F. M., Adams, L. B., & Gillis, J. (2023) · Nature Communications · doi:10.1038/s41467-023-43024-5 · Cited by 27
Integration of single‐cell transcriptome and proteome technologies: Toward spatial resolution levels
He, L., Wang, W., Dang, K., Ge, Q., & Zhao, X. (2023) · Open Research (University of Surrey) · doi:10.1002/viw.20230040 · Cited by 16
Pfisterer, U., Bräunig, J., Brattås, P. L., Heidenblad, M., Karlsson, G., & Fioretos, T. (2021) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22944 · Cited by 17
Decoding Cancer Evolution: Integrating Genetic and Non-Genetic Insights
Ashouri, A., Zhang, C., & Gaiti, F. (2023) · Genes · doi:10.3390/genes14101856 · Cited by 17
Self-citationBennett, R., Thompson, E. R., & Tam, C. S. L. (2022) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2022.07.013 · Cited by 18
Single-Cell Epigenomics in Cancer: Charting a Course to Clinical Impact
Bond, D. R., Uddipto, K., Enjeti, A. K., & Lee, H. J. (2020) · Epigenomics · doi:10.2217/epi-2020-0046 · Cited by 15
Tumor Profiling at the Service of Cancer Therapy
Fernández–Rozadilla, C., Simões, A. R., LLeonart, M. E., Carnero, A., & Carracedo, Á. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.595613 · Cited by 17
Single-cell technologies and analyses in hematopoiesis and hematological malignancies
Campillo‐Marcos, I., Álvarez‐Errico, D., Alandes, R. A., Mereu, E., & Esteller, M. (2021) · Experimental Hematology · doi:10.1016/j.exphem.2021.05.001 · Cited by 14
Epigenomic Characterization of Lymphoid Neoplasms
Duran‐Ferrer, M., & Martín-Subero, J. I. (2023) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051122-100856 · Cited by 16
New insights into Human Hematopoietic Stem and Progenitor Cells via Single-Cell Omics
Zhang, Y., Huang, Y., Hu, L., & Cheng, T. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10330-2 · Cited by 15
Microfluidics for Cancer Biomarker Discovery, Research, and Clinical Application
Žvirblytė, J., & Mažutis, L. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-04039-9_20 · Cited by 13
Epigenetic cancer evolution, one cell at a time
Perdigoto, C. N. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0143-1 · Cited by 13
The LL-100 Cell Lines Panel: Tool for Molecular Leukemia–Lymphoma Research
Drexler, H. G., & Quentmeier, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165800 · Cited by 15
The Crossroads of Clonal Evolution, Differentiation Hierarchy, and Ontogeny in Leukemia Development
Sturgeon, C. M., Wagenblast, E., Izzo, F., & Papapetrou, E. P. (2024) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-24-0235 · Cited by 12
Ahuja, P., Yadav, R., Goyal, S., Yadav, C., Ranga, S., & Kadian, L. K. (2023) · Cell Biology and Toxicology · doi:10.1007/s10565-023-09818-5 · Cited by 12
Single-cell epigenomics and proteomics methods integrated in multiomics
Bi, H., & Weng, X. (2024) · Fundamental Research · doi:10.1016/j.fmre.2023.11.014 · Cited by 12
Fong, J., Gardner, J. R., Andrews, J. M., Cashen, A. F., Payton, J. E., Weinberger, K. Q., & Edwards, J. R. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab516 · Cited by 11
In Human Visualization of Ibrutinib-Induced CLL Compartment Shift
Mayerhoefer, M. E., Haug, A. R., Jaeger, U., Pichler, V., Pfaff, S., Wester, H., Hacker, M., Kazianka, L., & Staber, P. B. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0880 · Cited by 12
Advances in Epigenomic Sequencing and Their Applications in Cancer Diagnostics
Lin, L., & Liu, Y. (2025) · Precision Chemistry · doi:10.1021/prechem.5c00014 · Cited by 11
Xu, F., Dong, M.-M., Wang, Z., & Cao, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1083069 · Cited by 14
Tumor Suppressors in Chronic Lymphocytic Leukemia: From Lost Partners to Active Targets
Andreani, G., Carrà, G., Lingua, M. F., Maffeo, B., Brancaccio, M., Taulli, R., & Morotti, A. (2020) · Cancers · doi:10.3390/cancers12030629 · Cited by 11
Ng, A. K. Y., & Chiorazzi, N. (2021) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2021.03.002 · Cited by 12
Domenico, A. D., Pipinikas, C., Maire, R., Bräutigam, K., Simillion, C., Dettmer, M. S., Vassella, E., Thirlwell, C., Perren, A. A., & Marinoni, I. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.08.029785 · Cited by 11
Charting single-cell lineages with synthetic and natural barcodes
Rodriguez-Fraticelli, A., & Parreno, V. (2026) · Nature Reviews Genetics · doi:10.1038/s41576-026-00943-5 · Cited by 11
The molecular map of CLL and Richter's syndrome
Sud, A., Parry, E. M., & Wu, C. J. (2024) · Seminars in Hematology · doi:10.1053/j.seminhematol.2024.01.009 · Cited by 10
Self-citationYe, B., Yang, L., Liu, B., Liu, N., Fan, D., Li, H., Sun, L., Du, Y., Wang, S., Tian, Y., et al. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00842-9 · Cited by 10
Can aggressive cancers be identified by the “aggressiveness” of their chromatin?
Gurova, K. V. (2022) · BioEssays · doi:10.1002/bies.202100212 · Cited by 9
How single-cell techniques help us look into lung cancer heterogeneity and immunotherapy
Liao, P., Huang, Q., Zhang, J., Su, Y., Xiao, R., Luo, S., Wu, Z., Zhu, L., Li, J., & Hu, Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1238454 · Cited by 10
RNA splicing as a therapeutic target in myelodysplastic syndromes
Tseng, C.-C., & Obeng, E. A. (2024) · Seminars in Hematology · doi:10.1053/j.seminhematol.2024.10.005 · Cited by 11
The evolution of leukaemia from pre‐leukaemic and leukaemic stem cells
Shlush, L. I., & Feldman, T. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13236 · Cited by 10
Pearson, H. C. L., Hunt, K. V., Trahair, T. N., Lock, R. B., Lee, H. J., & de Bock, C. E. (2022) · HemaSphere · doi:10.1097/hs9.0000000000000734 · Cited by 9
Kulis, M., & Martín-Subero, J. I. (2022) · British Journal of Haematology · doi:10.1111/bjh.18465 · Cited by 11
Nam, A. S., Dusaj, N. N., Izzo, F., Murali, R., Myers, R. M., Mouhieddine, T. H., Sotelo, J., Benbarche, S., Waarts, M. R., Gaiti, F., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.14.476225 · Cited by 10
Self-citationGuo, W., Chen, W., Zhang, J., Li, M., Huang, H., Wang, Q., Fei, X., Huang, J., Zheng, T., Fan, H., et al. (2025) · BMC Cancer · doi:10.1186/s12885-024-13380-6 · Cited by 9
Self-citationThe end of the beginning: application of single-cell sequencing to chronic lymphocytic leukemia
Nagler, A., & Wu, C. J. (2022) · Blood · doi:10.1182/blood.2021014669 · Cited by 9
Self-citationCopy number-aware deconvolution of tumor-normal DNA methylation profilesPreprint
Cadieux, E. L., Mensah, N., Castignani, C., Tanić, M., Wilson, G. A., Dietzen, M., Dhami, P., Vaikkinen, H., Verfaillie, A., Cotobal, C., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.03.366252 · Cited by 9
Gaiti, F., Chamely, P., Hawkins, A. G., Cortés-López, M., Swett, A. D., Ganesan, S., Mouhieddine, T. H., Dai, X., Kluegel, L., Chen, C. Y., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.08.495292 · Cited by 9
Self-citationLiu, Y., Li, X. C., Mehrabadi, F. R., Schäffer, A. A., Pratt, D. W., Crawford, D. R., Malikić, S., Molloy, E. K., Gopalan, V., Mount, S. M., et al. (2023) · Genome Research · doi:10.1101/gr.277608.122 · Cited by 8
Viewing AML through a New Lens: Technological Advances in the Study of Epigenetic Regulation
Godfrey, L., & Rodríguez-Meira, A. (2022) · Cancers · doi:10.3390/cancers14235989 · Cited by 7
Single-cell decoding of drug induced transcriptomic reprogramming in triple negative breast cancers
Kabeer, F., Tran, H., Andronescu, M., Singh, G., Lee, H., Salehi, S., Wang, B., Biele, J., Brimhall, J., Gee, D., et al. (2024) · Genome biology · doi:10.1186/s13059-024-03318-3 · Cited by 9
Methylation patterns at the adjacent CpG sites within enhancers are a part of cell identity
Taryma‐Leśniak, O., Bińkowski, J., Przybylowicz, P. K., Sokolowska, K. E., Borowski, K., & Wojdacz, T. K. (2024) · Epigenetics & Chromatin · doi:10.1186/s13072-024-00555-5 · Cited by 8
Altered DNA Methylation Profiles in SF3B1 Mutated CLL Patients
Pacholewska, A., Grimm, C., Herling, C., Lienhard, M., Königs, A., Timmermann, B., Altmüller, J., Mücke, O., Reinhardt, H. C., Plass, C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179337 · Cited by 8
Saeed, W. H., Eissa, A. A., & Al-Doski, A. A. (2019) · Journal of Blood Medicine · doi:10.2147/jbm.s221707 · Cited by 8
Epigenetic reprogramming in multiple myeloma—Challenges and opportunities
Kumar, S., Kats, L. M., & Gruber, E. (2025) · International Journal of Cancer · doi:10.1002/ijc.35426 · Cited by 8
Genetics and epigenetics of CLL
Paul, P., Stüssi, G., Bruscaggin, A., & Rossi, D. (2022) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2022.2153359 · Cited by 7
Radiomic features define risk and are linked to DNA methylation attributes in primary CNS lymphoma
Nenning, K., Gesperger, J., Furtner, J., Nemc, A., Roetzer-Pejrimovsky, T., Choi, S. W., Mitter, C., Leber, S. L., Hofmanninger, J., Klughammer, J., et al. (2023) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdad136 · Cited by 7
Genomic Instability and Clonal Evolution in Chronic Lymphocytic Leukemia: Clinical Relevance
Condoluci, A., & Rossi, D. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.7623 · Cited by 7
Mircea, M., & Semrau, S. (2021) · Biochemical Society Transactions · doi:10.1042/bst20210135 · Cited by 9
Biancotti, R., Pozzo, C. A. D., Parente, P., Businello, G., Angerilli, V., Realdon, S., Savarino, E. V., Farinati, F., Milanetto, A. C., Pasquali, C., et al. (2022) · Digestive Diseases · doi:10.1159/000525421 · Cited by 7
Barozzi, I., Slaven, N., Canale, E., Lopes, R., Barbosa, I. A. M., Bleu, M., Ivanoiu, D., Pacini, C., Mensa’, E., Chambers, A., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-1157 · Cited by 7
Reid, J. C., Golubeva, D., Boyd, A. L., Hollands, C. G., Henly, C., Orlando, L., Leber, A., Hébert, J., Morabito, F., Cutrona, G., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108845 · Cited by 7
Evolving strategies for lineage tracing: Genetic markers, synthetic barcodes, and natural variants
Kang, Z., Chen, H., Li, S., Wang, S., & Zhou, B. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.05.001 · Cited by 6
Nomura, M., Raviram, R., Schiffman, J. S., Bussema, L., Lu, V., Wheeler, N., Lee, J. J. Y., Fan, Y., Zheng, M. H., Ruiz, F., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02642-7 · Cited by 8
Self-citationGLP and G9a histone methyltransferases as potential therapeutic targets for lymphoid neoplasms
Silva-Carvalho, A. É., Filiú-Braga, L. D. D. C., Bogéa, G. M. R., de Assis, A. J. B., Pittella-Silva, F., & Saldanha‐Araújo, F. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03441-y · Cited by 6
Tumor evolution-targeted nanomedicineEVT
Zhang, L., Yang, J., Tang, D., Zhang, H., Ding, J., & Xiao, H. (2022) · Scientia Sinica Chimica · doi:10.1360/ssc-2022-0158 · Cited by 6
From Descriptive to Functional Genomics of Leukemias Focusing on Genome Engineering Techniques
Balla, B., Tripon, F., & Bănescu, C. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810065 · Cited by 6
Oder, B., Chatzidimitriou, A., Langerak, A. W., Rosenquist, R., & Österholm, C. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1143811 · Cited by 5
Biological, prognostic, and therapeutic impact of the epigenome in CLL
Maiqués-Díaz, A., & Martín-Subero, J. I. (2023) · Seminars in Hematology · doi:10.1053/j.seminhematol.2023.11.005 · Cited by 5
Johnson, N. D., Cutler, D. J., & Conneely, K. N. (2024) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2024.02.009 · Cited by 5
Epigenetics and alternative splicing in cancer: old enemies, new perspectives
Pandkar, M. R., & Shukla, S. (2024) · Biochemical Journal · doi:10.1042/bcj20240221 · Cited by 6
DNA methylation dynamics in the shoot apical meristem
Yang, J., & Johannes, F. M. (2025) · Journal of Experimental Botany · doi:10.1093/jxb/eraf024 · Cited by 6
Single-cell lineage tracing techniques in hematology: unraveling the cellular narrative
Deng, L.-H., Li, M., Huang, X., & Zhao, X. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06318-4 · Cited by 5
A ternary-code DNA methylome atlas of mouse tissues
Lee, S. M., Goldberg, D. C., Cloud, C., Parker, J. B., Krapp, C. J., Loo, C. E., Kim, E., Zhao, I., Jin, C., Porecha, R., et al. (2025) · Genome biology · doi:10.1186/s13059-025-03808-y · Cited by 4
SOHO State of the Art Updates and Next Questions: Clonal Evolution in Chronic Lymphocytic Leukemia
Condoluci, A., & Rossi, D. (2020) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2020.08.029 · Cited by 5
DNA methylation meets lineage tracing: History, recent progress, and future directions
Fu, R., Chen, M., & Wang, S. (2025) · Quantitative Biology · doi:10.1002/qub2.70017 · Cited by 4
Materiobiology in the omics era
Song, P., Wu, Y., Zhang, C., Zhou, F., Bai, L., & Su, J. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102539 · Cited by 5
Effect of epigenetic changes in hypoxia induced factor (HIF) gene across cancer types
Agarwal, A. P., & Kumar, M. S. (2024) · Gene · doi:10.1016/j.gene.2024.149047 · Cited by 5
Computational approaches for multimodal lineage tracing
Wang, K., He, X., & Hu, Z. (2026) · Nature Reviews Genetics · doi:10.1038/s41576-026-00969-9 · Cited by 7
The mechanistic GEMMs of oncogenic histones
Lindroth, A. M., Park, Y. J., Matía, V., & Squatrito, M. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa143 · Cited by 4
Cause and effect in epigenetics – where lies the truth, and how can experiments reveal it?
Klutstein, M. (2020) · BioEssays · doi:10.1002/bies.202000262 · Cited by 4
Clonal dynamics in chronic lymphocytic leukemia
Gutierrez, C., & Wu, C. J. (2019) · Hematology · doi:10.1182/hematology.2019000367 · Cited by 4
Self-citationSingle-cell technologies: a new lens into epigenetic regulation in development
Bolondi, A., Kretzmer, H., & Meissner, A. (2022) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2022.101947 · Cited by 4
Self-citationMai, L., Wen, Z., Zhang, Y., Gao, Y., Lin, G., Lian, Z., Yang, X., Zhou, J., Lin, X., Luo, C., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad892 · Cited by 4
Contributions of transcriptional noise to leukaemia evolution: KAT2A as a case-study
Pina, C. (2024) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2023.0052 · Cited by 6
Interweaving Tumor Heterogeneity into the Cancer Epigenetic/Metabolic Axis
Leung, J. Y., Chia, K., Ong, D. S. T., & Taneja, R. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7942 · Cited by 4
Derrien, J., Guérin‐Charbonnel, C., Gaborit, V., Campion, L., Devic, M., Douillard, E., Roi, N., Avet‐Loiseau, H., Decaux, O., Facon, T. T. F., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.01.321943 · Cited by 4
H3K27me3 is a determinant of chemotolerance in triple-negative breast cancerPreprint
Marsolier, J., Prompsy, P., Durand, A., Lyne, A.-M., Landragin, C., Trouchet, A., Bento, S. T., Eisele, A. S., Foulon, S., Baudre, L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.04.423386 · Cited by 4
Evolutionary dynamics of 1,976 lymphoid malignancies predict clinical outcomePreprint
Gabbutt, C., Duran‐Ferrer, M., Grant, H. E., Mallo, D., Nadeu, F., Househam, J., Villamor, N., Krali, O., Nordlund, J., Zenz, T., et al. (2023) · medRxiv · doi:10.1101/2023.11.10.23298336 · Cited by 4
Clonal tracing of blood stem cells across mouse and human lifespans
Rodriguez-Fraticelli, A. (2025) · Blood · doi:10.1182/blood.2024028195 · Cited by 4
Yang, Q., Qiao, C., Liu, W. W., Jiang, H., Jing, Q., Liao, Y., & Xing, Y. (2021) · Animal Genetics · doi:10.1111/age.13105 · Cited by 3
LISA2: Learning Complex Single-Cell Trajectory and Expression Trends
Chen, Y., Zhang, Y., Li, J. Y. H., & Ouyang, Z. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.681206 · Cited by 3
Single-cell genomics-based immune and disease monitoring in blood malignancies
Rathgeber, A. C., Ludwig, L. S., & Penter, L. (2024) · Clinical Hematology International · doi:10.46989/001c.117961 · Cited by 4
Single cell biology—a Keystone Symposia report
Cable, J., Elowitz, M. B., Domingos, A. I., Habib, N., Itzkovitz, S., Hamidzada, H., Balzer, M. S., Yanai, I., Liberali, P., Whited, J. L., et al. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14692 · Cited by 4
Self-citationGregg, C. J. (2021) · Frontiers in Ecology and Evolution · doi:10.3389/fevo.2021.693781 · Cited by 4
Mimmi, S., Maisano, D., Dattilo, V., Gentile, M., Chiurazzi, F., d’Ambrosio, A., Zimbo, A. M., Nisticò, N., Aloisio, A., Vecchio, E., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10030604 · Cited by 3
Kaufman, M. S., Yan, X., Li, W., Ghia, E. M., Langerak, A. W., Rassenti, L. Z., Belessi, C., Kay, N. E., Davi, F., Byrd, J. C., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.897280 · Cited by 3
Epialleles and epiallelic heterogeneity in hematological malignancies
Benetatos, L., Benetatou, A., & Vartholomatos, G. (2022) · Medical Oncology · doi:10.1007/s12032-022-01737-5 · Cited by 3
Slaven, N., Lopes, R., Canale, E., Ivanoiu, D., Pacini, C., Barbosa, I. A. M., Bleu, M., Bravaccini, S., Ravaioli, S., Dieci, M. V., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.15.480537 · Cited by 3
Sequencing-based methods for single-cell multi-omics studies
Qin, S., Liu, S., & Weng, X. (2023) · Science China Chemistry · doi:10.1007/s11426-023-1793-7 · Cited by 2
Metadata
- Authors
- Gaiti, F., Chaligne, R., Gu, H., Brand, R. M., Kothen-Hill, S., Schulman, R. C., Grigorev, K., Risso, D., Kim, K.-T., Pastore, A., Huang, K. Y., Alonso, A., Sheridan, C., Omans, N. D., Biederstedt, E., Clement, K., Wang, L., Felsenfeld, J. A., Bhavsar, E. B., Aryee, M. J., Allan, J. N., Furman, R., Gnirke, A., Wu, C. J., Meissner, A., & Landau, D. A.
- Affiliations
- New York Genome Center (US)
- Broad Institute (US)
- Weill Cornell Medicine (US)
- University of Padua (IT)
- Memorial Sloan Kettering Cancer Center (US)
- City of Hope (US)
- Corresponding author
- Landau, Dan A.
- ORCID
- Venue
- Nature
- Published
- 2019-05-15
- Volume
- 569
- Issue
- 7757
- Pages
- 576-580
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6533116
- OpenAlex
- W2946801856
- Cited by
- 262
- References
- 73
- Citations by year
- 2026: 18 · 2025: 27 · 2024: 34 · 2023: 37 · 2022: 51 · 2021: 51 · 2020: 35 · 2019: 9
- FWCI
- 20.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- Funders
- National Institutes of Health (1dp2ca239065-01, 5r01ca229902-05)
- National Heart, Lung, and Blood Institute (R01HL145283)
- National Cancer Institute (R01CA240910, DP2-CA239065, R01-CA229902, R01CA216273, UG1CA233338, P30CA008748, P01CA206978, P30CA006516)
- National Institute of Environmental Health Sciences (K01ES025431)
- Topics
- Health Sciences › Medicine › Hematology › Chronic Lymphocytic Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- chronic lymphocytic leukemia, epimutations, DNA methylation, epigenetic evolution, intratumoral heterogeneity, clonal evolution, lineage reconstruction, ibrutinib resistance, B cell differentiation, single-cell bisulfite sequencing, single-cell transcriptomics
- MeSH terms
- Epigenome, Base Sequence, Biological Clocks, Humans, Transcription, Genetic, Leukemia, Lymphocytic, Chronic, B-Cell, Gene Expression Regulation, Neoplastic, Sequence Analysis, RNA, Cell Lineage, Evolution, Molecular, DNA Methylation, Epigenesis, Genetic, Single-Cell Analysis, Mutation Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
